Xiaolin Tu

Xiaolin Tu


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2025 in npj Microgravity
Verified
Journal Article
Open access
PDF file
HZHaoyang Zhao
Haoyang Zhao
MYMengfan Yang
Mengfan Yang
YLYujiao Liu
Yujiao Liu
XTXiaolin Tu
Xiaolin Tu
GSGaohai Shao
Gaohai Shao
Disuse osteoporosis, caused by mechanical unloading, is linked to dysregulated TGFβ and BMP signaling. This study explores their roles and evaluates BMP9 as a potential therapy. A hindlimb unloading (HLU) mouse model was used to assess bone changes and signaling alterations. In vitro, a Rotary Cell Culture System (RCCS) with 3D printing simulated microgravity. BMP9 was overexpressed in bone marrow stromal cells (BMSCs) and osteocytes treated with TGFβ1. HLU mice showed reduced bone density, microstructural integrity, and dysregulated signaling (increased p-Smad2/3, decreased p-Smad1/5/8). BMP9 overexpression restored osteogenic differentiation in vitro and improved bone properties in vivo. However, RCCS failed to replicate osteogenic inhibition, likely due to shear stress. Despite challenges, BMP9 shows promise for treating disuse osteoporosis. Future research will refine vector specificity and reduce immunogenicity for clinical application.

12 May 2026 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
MYMengfan Yang
Mengfan Yang
PLPei Liu
Pei Liu
HZHongjun Zhang
Hongjun Zhang
XTXun Tang
Xun Tang
XHXiang Hong
Xiang Hong
GSGaohai Shao
Gaohai Shao
Background: Osteosarcoma, the most common primary malignant bone tumor, predominantly affects adolescents and is characterized by high aggressiveness and early metastatic propensity. Chemoresistance and recurrence remain major clinical challenges, highlighting the urgent need for novel therapeutic targets and molecular mechanisms. Methods: Bioinformatics analysis of the GEO dataset (GSE42352) revealed a negative correlation between Wnt target gene expression and ferroptosis‑related gene signatures. The expression of Wnt and ferroptosis pathway genes/proteins, as well as autophagy and pyroptosis markers, was validated in 143B and MG63 cells by qRT‑PCR and Western blotting. ROS, Fe 2+ , and lipid peroxidation levels were measured using DCFH‑DA, FerroOrange, and Liperfluo, respectively. Mitochondrial morphology was assessed by transmission electron microscopy (TEM). Cell proliferation, migration, and invasion were evaluated by live/dead staining, wound healing assay, and Transwell invasion assay, respectively. Functional roles of HO‑1 and ACSL4 were validated via siRNA‑mediated knockdown in 143B cells. An osteosarcoma xenograft model was established; tumor expression of ACSL4, HO‑1, and Ki67 was examined by IHC, and serum ferritin levels were measured by ELISA. Results: Bioinformatics analysis of the GEO dataset (GSE42352) revealed a negative correlation between Wnt target gene expression and ferroptosis‑related gene signatures, suggesting that ferroptosis may be involved. In 143B and MG‑63 cells, LF3 (40 μM) downregulated Wnt target genes (AXIN2, BMP4, SMAD6, LEF1) and TCF4 protein expression, significantly inhibiting cell proliferation, migration, and invasion. LF3 treatment induced ROS elevation, lipid peroxidation, and characteristic mitochondrial morphological changes, independent of apoptosis, autophagy, or pyroptosis. Mechanistic studies demonstrated that LF3 activated ferroptosis through upregulation of HO‑1 and ACSL4/LPCAT3. In an osteosarcoma xenograft model, LF3 reduced tumor volume by approximately 60%, accompanied by elevated serum ferritin and tumor 4‑HNE levels; these effects were partially reversed by DFO co‑treatment. No systemic toxicity was observed. Conclusion: These findings establish LF3 as a dual-targeting agent that overcomes osteosarcoma through coordinated Wnt suppression and ferroptosis activation via the HO-1/ACSL4 axis, providing a novel therapeutic strategy for chemoresistant osteosarcoma.